* Oct. 30, 10:30 a.m. — Jennifer Doudna, the 2020 Nobel laureate in chemistry, will speak about her work on CRISPR and its intersections with COVID-19 at the upcoming . The free, online event, co-organized by the °ÄÃÅÁùºÏ²Ê¿ª½±½á¹û×ßÊÆͼ Office of Research and the School of Medicine, will be live, but registration is required.
is a Howard Hughes Medical Institute investigator at UC Berkeley and founder of the Innovative Genomics Institute. She is also the Li Ka Shing Chancellor’s Chair and a professor in the departments of Chemistry, and Molecular and Cell Biology.
Doudna and Emmanuelle Charpentier, director of the Max Planck Institute for Infection Biology, Oct. 7 for their co-development of CRISPR-Cas9, a genome-editing tool that has revolutionized biomedicine and agriculture. Doudna and Charpentier are the first women to share a Nobel in the sciences.
Media Resources
Andy Fell, News and Media Relations, 530-752-4533, ahfell@ucdavis.edu
Nadine A. Yehya, °ÄÃÅÁùºÏ²Ê¿ª½±½á¹û×ßÊÆͼ Health Public Affairs, 916-734-9040, nyehya@ucdavis.edu